# Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant

> **NCT02600988** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 150 (actual)

## Conditions studied

- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** 1000IU/day of Vitamine D
- **DRUG:** 5000IU/day of Vitamine D

## Key facts

- **NCT ID:** NCT02600988
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2015-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02600988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02600988, "Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02600988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*